A detailed history of Bessemer Group Inc transactions in Johnson & Johnson stock. As of the latest transaction made, Bessemer Group Inc holds 786,354 shares of JNJ stock, worth $120 Million. This represents 0.21% of its overall portfolio holdings.

Number of Shares
786,354
Previous 753,873 4.31%
Holding current value
$120 Million
Previous $110 Million 15.66%
% of portfolio
0.21%
Previous 0.19%

Shares

29 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Nov 12, 2024

BUY
$145.48 - $167.38 $4.73 Million - $5.44 Million
32,481 Added 4.31%
786,354 $127 Million
Q2 2024

Aug 13, 2024

SELL
$144.38 - $157.78 $4.24 Million - $4.63 Million
-29,365 Reduced 3.75%
753,873 $110 Million
Q1 2024

May 13, 2024

BUY
$155.22 - $162.74 $5.17 Million - $5.42 Million
33,301 Added 4.44%
783,238 $124 Million
Q4 2023

Feb 09, 2024

SELL
$145.6 - $158.88 $13.3 Million - $14.6 Million
-91,612 Reduced 10.89%
749,937 $118 Million
Q3 2023

Nov 13, 2023

BUY
$155.75 - $174.48 $26.7 Million - $29.9 Million
171,382 Added 25.57%
841,549 $131 Million
Q2 2023

Aug 10, 2023

BUY
$154.35 - $166.11 $64.3 Million - $69.2 Million
416,596 Added 164.29%
670,167 $111 Million
Q1 2023

May 10, 2023

SELL
$151.05 - $180.26 $1.52 Million - $1.81 Million
-10,031 Reduced 3.81%
253,571 $39.3 Million
Q4 2022

Feb 13, 2023

SELL
$160.2 - $179.79 $1.48 Million - $1.66 Million
-9,219 Reduced 3.38%
263,602 $46.6 Million
Q3 2022

Nov 09, 2022

SELL
$161.33 - $179.52 $338,793 - $376,992
-2,100 Reduced 0.76%
272,821 $44.6 Million
Q2 2022

Aug 10, 2022

SELL
$168.19 - $186.01 $4.75 Million - $5.26 Million
-28,268 Reduced 9.32%
274,921 $48.8 Million
Q1 2022

May 12, 2022

SELL
$158.14 - $179.59 $8.52 Million - $9.68 Million
-53,896 Reduced 15.09%
303,189 $53.7 Million
Q4 2021

Jan 27, 2022

BUY
$155.93 - $173.01 $11.6 Million - $12.8 Million
74,251 Added 26.25%
357,085 $61.1 Million
Q3 2021

Nov 12, 2021

BUY
$161.5 - $179.47 $10.1 Million - $11.3 Million
62,785 Added 28.53%
282,834 $45.7 Million
Q2 2021

Aug 06, 2021

BUY
$159.48 - $171.07 $710,961 - $762,630
4,458 Added 2.07%
220,049 $36.3 Million
Q1 2021

May 13, 2021

BUY
$153.07 - $170.48 $1.36 Million - $1.52 Million
8,904 Added 4.31%
215,591 $35.4 Million
Q4 2020

Feb 09, 2021

SELL
$137.11 - $157.38 $5.92 Million - $6.79 Million
-43,144 Reduced 17.27%
206,687 $32.5 Million
Q3 2020

Nov 12, 2020

SELL
$140.38 - $153.83 $2.63 Million - $2.88 Million
-18,746 Reduced 6.98%
249,831 $37.2 Million
Q2 2020

Aug 05, 2020

BUY
$128.81 - $155.51 $3.23 Million - $3.9 Million
25,097 Added 10.31%
268,577 $37.8 Million
Q1 2020

Apr 30, 2020

BUY
$111.14 - $153.99 $5.46 Million - $7.56 Million
49,097 Added 25.26%
243,480 $31.9 Million
Q4 2019

Feb 04, 2020

BUY
$127.5 - $146.44 $1.71 Million - $1.96 Million
13,397 Added 7.4%
194,383 $28.4 Million
Q3 2019

Nov 07, 2019

BUY
$126.95 - $142.14 $1.49 Million - $1.67 Million
11,715 Added 6.92%
180,986 $23.4 Million
Q2 2019

Jul 19, 2019

SELL
$131.15 - $144.24 $1.04 Million - $1.15 Million
-7,955 Reduced 4.49%
169,271 $23.6 Million
Q1 2019

May 13, 2019

SELL
$125.72 - $139.79 $3.41 Million - $3.79 Million
-27,100 Reduced 13.26%
177,226 $24.8 Million
Q4 2018

Feb 12, 2019

SELL
$122.84 - $147.84 $187 Million - $225 Million
-1,523,346 Reduced 88.17%
204,326 $26.4 Million
Q3 2018

Nov 06, 2018

SELL
$121.58 - $142.88 $33.8 Million - $39.7 Million
-277,676 Reduced 13.85%
1,727,672 $239 Million
Q2 2018

Jul 25, 2018

BUY
$119.4 - $131.76 $16.5 Million - $18.2 Million
138,051 Added 7.39%
2,005,348 $243 Million
Q1 2018

May 10, 2018

BUY
$125.1 - $148.14 $6.54 Million - $7.74 Million
52,265 Added 2.88%
1,867,297 $239 Million
Q4 2017

Jan 30, 2018

SELL
$131.22 - $143.62 $8.97 Million - $9.82 Million
-68,365 Reduced 3.63%
1,815,032 $254 Million
Q3 2017

Nov 03, 2017

BUY
$129.47 - $135.38 $244 Million - $255 Million
1,883,397
1,883,397 $245 Million

Others Institutions Holding JNJ

About JOHNSON & JOHNSON


  • Ticker JNJ
  • Exchange NYSE
  • Sector Healthcare
  • Industry Drug Manufacturers—General
  • Shares Outstandng 2,614,479,872
  • Market Cap $398B
  • Description
  • Johnson & Johnson, together with its subsidiaries, researches and develops, manufactures, and sells various products in the healthcare field worldwide. The company's Consumer Health segment offers baby care products under the JOHNSON'S and AVEENO Baby brands; oral care products under the LISTERINE brand; skin health/beauty products under the...
More about JNJ
Track This Portfolio

Track Bessemer Group Inc Portfolio

Follow Bessemer Group Inc and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Bessemer Group Inc, based on Form 13F filings with the SEC.

News

Stay updated on Bessemer Group Inc with notifications on news.